AzTrials
AzTrials

Activity, MotorNCT05835544

Acute High Intensity Interval Training and Blood Flow Restriction

A study testing Experimental: HIIT + BFR between cycling sets, Experimental: HIIT + BFR moderate occlusion during cycling and Experimental: HIIT + BFR high occlusion during cycling in people with Activity, Motor, run by Nanyang Technological University at 1 site in Singapore.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study aims to look at the blood flow restriction (BFR) + high intensity interval training (HIIT) variables to induce an optimal acute training stimulus (i.e., acute responses in main outcome measures of muscular activation, muscular deoxygenation, and secondary outcome measures of heart rate (HR), blood lactate… Read more about this study

Who is it for?
Ages 18 to 40 years, men onlyHealthy volunteers can take part
Conditions the study is for
Activity, Motor
What is being tested?
Experimental: HIIT + BFR between cycling sets, Experimental: HIIT + BFR moderate occlusion during cycling and Experimental: HIIT + BFR high occlusion during cycling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteSingapore
Study dates
1 Aug 2022to 31 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male
  • Age: 18-40 years
  • Competed in competitive varsity sports (endurance, tennis, badminton, squash, football, basketball, etc.) at the varsity/club level
  • Actively training for at least 2 sessions (1 - 1.5h) per week
  • Healthy (free from illnesses) and no musculoskeletal injuries for the past 6 months
  • No history of cardiometabolic, vascular diseases or similar conditions (high blood pressure, peripheral vascular diseases, heart diseases, metabolic syndrome, diabetes, stroke, etc.).
Show all 10Show fewer
  • Pass pre-participation health screening tests - Physical Activity Readiness Questionnaire for Everyone (PAR-Q+) and Australian Institute of Sport (AIS) Blood Flow Restriction (BFR) pre-screening questionnaire (no history of any risk factors).
  • Maximal oxygen uptake (VO2max) of ≥40mmol/min/kg during a maximal aerobic cycling test.
  • Non-smoker
  • Drink alcohol less than 3 times each week and less than 3 drinks each time

Who cannot join

  • Any diagnosed form of cardiometabolic disease (CVD, diabetes, metabolic syndrome, hypertension)
  • Any symptoms contraindication of exercise testing (eg chest pains)
  • Any balance or dizziness problems
  • Any chronic medical conditions (whether medicated or not)
  • Any bone joint problems
  • Any Physician diagnosed contraindications to exercise

Trial locations and contacts

1 site in 1 country.

Singapore1 site
  • Human Bioenergetics Laboratory, National Institute of Education, Nanyang Technological University

    Singapore, 637616

Other trials in Singapore

About this study

Official title: Acute Responses to High-intensity Interval Exercise (HIIE) and Blood Flow Restriction (BFR)

The study aims to look at the blood flow restriction (BFR) + high intensity interval training (HIIT) variables to induce an optimal acute training stimulus (i.e., acute responses in main outcome measures of muscular activation, muscular deoxygenation, and secondary outcome measures of heart rate (HR), blood lactate (bLa), subjective ratings of perceived exertion and discomfort)

The hypotheses for this study are: (i) BFR increases muscular deoxygenation, muscular activation when HIIT exercise is of the same intensity, (ii) however, comparing between a lower BFR + HIIT exercise intensity (e.g. 80% V̇O2max) and higher HIIT exercise intensity (e.g. 100% V̇O2max), muscular deoxygenation and activation will be similar but HR will be lower in the BFR + HIIT condition.

Read the detailed description

This study revolves around the optimisation of blood flow restriction (BFR) and high-intensity interval training (HIIT) protocols for the racket sport athlete. The study aims to look at the BFR + HIIT variables to induce an optimal acute training stimulus. This can be achieved with the consideration of two main research questions: (i) What is the ideal combination of BFR cuff pressure and exercise intensity (i.e. cycling) to elicit favourable training stimuli, i.e., acute responses in main outcome measures of muscular activation, muscular deoxygenation, and secondary outcome measures of heart rate (HR), blood lactate (bLa), subjective ratings of perceived exertion and discomfort?; (ii) How does BFR + HIIT compare with traditional HIIT at a similar or higher exercise intensity in terms of these acute responses?

The hypotheses for this study are: (i) BFR increases muscular deoxygenation, muscular activation when HIIT exercise is of the same intensity, (ii) however, comparing between a lower BFR + HIIT exercise intensity (e.g. 80% V̇O2max) and higher HIIT exercise intensity (e.g. 100% V̇O2max), muscular deoxygenation and activation will be similar but HR will be lower in the BFR + HIIT condition.

Conditions
Activity, Motor
Being tested
Active Comparator: HIIT Control, Experimental: HIIT + BFR between cycling sets, Experimental: HIIT + BFR moderate occlusion during cycling, Experimental: HIIT + BFR high occlusion during cycling
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Active Comparator: HIIT ControlOther

    Complete 3 sets of five repetitions of 30 seconds cycling at 100% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets.

  • Experimental: HIIT + BFR between cycling setsOther

    Complete 3 sets of five repetitions of 30 seconds cycling at 100% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied for 2 minutes during the passive rest at 80% of limb occlusion pressure.

  • Experimental: HIIT + BFR moderate occlusion during cyclingOther

    Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 50% of limb occlusion pressure and deflated during passive rest periods.

  • Experimental: HIIT + BFR high occlusion during cyclingOther

    Complete 3 sets of five repetitions of 30 seconds cycling at 70% of maximal aerobic power with 30 seconds of active unloaded recovery between repetitions; 3 minutes of passive rest between sets. Blood flow restriction is applied during and between exercise repetitions at 80% of limb occlusion pressure and deflated during passive rest periods.

Study groups in NCT05835544
Study groupRoleWhat they receive
HIIT ControlActive comparatorHigh intensity interval cycling
Receives: Other: Active Comparator: HIIT Control
HIIT + BFR between cycling setsExperimentalHigh intensity interval cycling with blood flow restriction applied between sets of cycling
Receives: Other: Experimental: HIIT + BFR between cycling sets
HIIT + BFR moderate occlusion during cyclingExperimentalHigh intensity interval cycling with moderate blood flow restriction applied during cycling
Receives: Other: Experimental: HIIT + BFR moderate occlusion during cycling
HIIT + BFR high occlusion during cyclingExperimentalHigh intensity interval cycling with high blood flow restriction applied during cycling
Receives: Other: Experimental: HIIT + BFR high occlusion during cycling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate

    Heart rate using short-range telemetry

    Measured: Measured and compared between each acute arm (condition)

  2. Blood lactate concentration

    Fingertip capillary measure

    Measured: Measured and compared between each acute arm (condition)

  3. Muscle activation

    Surface electromyography of the vastus lateralis and biceps femoris muscles to determine electrical activity of the motor units (physiological parameter)

    Measured: Measured and compared between each acute arm (condition)

  4. Muscle oxygenation

    Near infra-red spectroscopy to examine regional tissue (the vastus lateralis muscle) oxygenation i.e, the percentage of haemoglobin and deoxyhaemoglobin (physiological parameter)

    Measured: Measured and compared between each acute arm (condition)

Secondary outcomes (2)
  1. Rating of perceived exertion

    Borg Rating of Perceived Exertion scale 6-20 (6 = no exertion at all; 20 = maximal exertion)

    Measured: Measured and compared between each acute arm (condition)

  2. Exertion and Pain scale

    Borg Category-Ratio (CR) 10 scale (0 = No exertion at all; 10 = Maximal)

    Measured: Measured and compared between each acute arm (condition)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2023
  2. Study start1 Aug 2022
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05835544
Sponsor's protocol ID
IRB-2022-135
Status last verified
Apr 2024
First submitted
5 Apr 2023
Last updated
3 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All published data will be placed into the Data Repository of Nanyang Technological University National Institute of Education for public access upon publication.

Publications

  • Chua M, Sim A, Burns SF. Acute physiological and perceptual responses to three blood flow restricted interval exercise protocols: a randomised controlled trial. Appl Physiol Nutr Metab. 2025 Jan 1;50:1-13. doi: 10.1139/apnm-2024-0423.

    PubMed 39919270

Questions about this trial

What is this clinical trial studying?

A study testing Experimental: HIIT + BFR between cycling sets, Experimental: HIIT + BFR moderate occlusion during cycling and Experimental: HIIT + BFR high occlusion during cycling in people with Activity, Motor, run by Nanyang Technological University at 1 site in Singapore.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate (time frame: Measured and compared between each acute arm (condition)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05835544, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in